鲁抗医药：关于开立募集资金现金管理专用结算账户并使用部分闲置募集资金进行现金管理的公告

Core Viewpoint - The company, LuKang Pharmaceutical, has announced a plan to utilize part of its idle raised funds for cash management, ensuring that it does not affect the normal operation of investment projects [2] Group 1: Company Announcement - On January 23, 2026, LuKang Pharmaceutical held the twelfth (temporary) meeting of the eleventh board of directors to approve the proposal for cash management using idle raised funds [2] - The company will use an amount not exceeding RMB 31 million for cash management, with a validity period of 12 months from the date of board approval [2] - A dedicated settlement account for cash management products has been opened at the Jining Jin Yu Road Branch of China Postal Savings Bank [2]